Adia Med, Inc. (ADIA) income statement
ADIAOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.13−0.01 (-7.14%)
Close on Oct 19, 2026Market cap $20.98MP/E –Yield –
Adia Med, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 27.4%
- Operating margin
- -52.3%
- Net margin
- -56.5%
- Return on equity, FY2025
- 340.7%
Financial strength
- Current ratio
- 0.32
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 12.1%
Valuation
- P/E ratio
- –
- Price to sales
- 29.95
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?